As practices adopt the Oncology Care Model, practices should consider how this change will influence the practice and make efforts to continue engaging with the staff during this process, said Basit Chaudhry, MD, PhD, founder of Tuple Health.
As practices adopt the Oncology Care Model, practices should consider how this change will influence the practice and make efforts to continue engaging with the staff during this process, said Basit Chaudhry, MD, PhD, founder of Tuple Health.
Transcript (slightly modified)
The Oncology Care Model requires major changes to how a practice operates. How can they more easily make the transition?
I think a key thing in practice transformation is really understanding what the experience is like for your staff. I think talking with them and really getting their feedback as you are going through this kind of change is really a fundamental importance.
One of the practices that I work with very closely, they have a phrase inside that basically summarizes to “and just one more thing.” That kind of means that with all this change going on, they are always asked to do “and just one more thing,” and each thing may not seem really big but they just keep adding up and adding up and adding up. I think it is really important to engage your staff, engage your nurses, your care coordinators, and really understand what their experience is like and really learn from them about what’s needed to change the way the practice functions.
Are practices participating in OCM often participating in other payment models? If so, how does that impact the practice?
Yeah, I think that the issue between commercial and OCM is a really important one. Many of the participants are in multiple models and I think that creates some tension at times, but I think it also creates alignment because it enables people to use their care coordination function more broadly and develop economies of scale. So, I think there’s been really positive alignment for many of them. There are differences between the different models and I think that’s something the Community Oncology Alliance has provided a great deal of leadership on, trying to align that to reduce the complexity of implementing the different payment models that we see in the public sector and private sector.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More